DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Rhythm Pharmaceuticals Q4 EPS $(0.78) Beats $(0.89) Estimate

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.89) by 12.36 percent. This is a 5.41 percent decrease over losses of $(0.74) per share

Benzinga · 03/02/2020 13:13

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.89) by 12.36 percent. This is a 5.41 percent decrease over losses of $(0.74) per share from the same period last year.